Manchester Financial Inc Soleno Therapeutics Inc Transaction History

Manchester Financial Inc

  • $433 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 26, 2021
SELL
$1.61 - $2.23 $3,220 - $4,460
-2,000 Closed
0 $0
Q1 2020

Apr 20, 2020
BUY
$1.64 - $3.85 $3,280 - $7,700
2,000 New
2,000 $5,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $468M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Manchester Financial Inc Portfolio

Follow Manchester Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email